Compass Therapeutics to present at H.C. Wainwright BioConnect investor conference

Compass Therapeutics

Compass Therapeutics

CMPX

0.00
  • Compass Therapeutics will present at H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq on May 19, 2026.
  • Presentation set for 1:30 p.m. ET.
  • Company will also present at 2026 Stifel Virtual Targeted Oncology Forum on May 20, 2026.
  • Presentation set for 11:30 a.m. ET.
  • Management plans to hold one-on-one investor meetings during both events.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compass Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605120730PRIMZONEFULLFEED9717531) on May 12, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.